Johnson & Johnson JNJ

$ 235.37 -0.94%

Annual report 2025
added 02-11-2026

Johnson & Johnson DIO Ratio 2011-2026 | JNJ

Annual DIO Ratio Johnson & Johnson

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
161	157	148	154	60	-	120	116	137	137	-	131	133	113	104

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
161	60	129

Quarterly DIO Ratio Johnson & Johnson

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
172	156	157	162	156	158	166	181	173	-	86.3	63.3	122	-	129	121	64.3	-	124	127	116	-	120	119	122	-	119	113	120	-	116	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
181	63.3	130

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Axsome Therapeutics AXSM	168	$ 156.92	-1.23 %	$ 7.81 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	BioMarin Pharmaceutical BMRN	644	$ 54.13	-1.64 %	$ 10.4 B	USA
	Coherus BioSciences CHRS	97.5	$ 1.52	-5.59 %	$ 178 M	USA
	Clovis Oncology CLVS	271	-	-7.23 %	$ 13 M	USA